Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Sell
19
MEDX Quote, Financials, Valuation and Earnings
Last price:
$25.03
Seasonality move
:
0%
Day range:
$24.22 - $24.78
52-week range:
$23.46 - $32.00
Dividend yield:
1.85%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
759
Avg. volume:
1.5K
1-year change:
-12.7%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
$24.78 | -- | -- | -- | $0.51 | 1.85% | -- |
|
AGNG
Global X Aging Population ETF
|
$29.14 | -- | -- | -- | $0.15 | 0.86% | -- |
|
CANC
Tema Oncology ETF
|
$22.52 | -- | -- | -- | $0.73 | 2.22% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$24.84 | -- | -- | -- | $0.12 | 1.93% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$27.36 | -- | -- | -- | $0.47 | 0.52% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$82.01 | -- | -- | -- | $0.52 | 2.07% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.860 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.900 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 1.131 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 0.835 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.175 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.625 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
Horizon Kinetics Medical ETF vs. Competitors
-
Which has Higher Returns MEDX or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About MEDX or AGNG?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than Global X Aging Population ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is MEDX or AGNG More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.798, suggesting its less volatile than the S&P 500 by 20.223%.
-
Which is a Better Dividend Stock MEDX or AGNG?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.85%. Global X Aging Population ETF offers a yield of 0.86% to investors and pays a quarterly dividend of $0.15 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or AGNG?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns MEDX or CANC?
Tema Oncology ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About MEDX or CANC?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than Tema Oncology ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is MEDX or CANC More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDX or CANC?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.85%. Tema Oncology ETF offers a yield of 2.22% to investors and pays a quarterly dividend of $0.73 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or CANC?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns MEDX or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About MEDX or FTXH?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is MEDX or FTXH More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.659, suggesting its less volatile than the S&P 500 by 34.143%.
-
Which is a Better Dividend Stock MEDX or FTXH?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.85%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.93% to investors and pays a quarterly dividend of $0.12 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or FTXH?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns MEDX or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About MEDX or HRTS?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is MEDX or HRTS More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDX or HRTS?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.85%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.52% to investors and pays a quarterly dividend of $0.47 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or HRTS?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns MEDX or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to Horizon Kinetics Medical ETF's net margin of --. Horizon Kinetics Medical ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MEDXHorizon Kinetics Medical ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About MEDX or PPH?
Horizon Kinetics Medical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Horizon Kinetics Medical ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe Horizon Kinetics Medical ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings MEDXHorizon Kinetics Medical ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is MEDX or PPH More Risky?
Horizon Kinetics Medical ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.672%.
-
Which is a Better Dividend Stock MEDX or PPH?
Horizon Kinetics Medical ETF has a quarterly dividend of $0.51 per share corresponding to a yield of 1.85%. VanEck Pharmaceutical ETF offers a yield of 2.07% to investors and pays a quarterly dividend of $0.52 per share. Horizon Kinetics Medical ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDX or PPH?
Horizon Kinetics Medical ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. Horizon Kinetics Medical ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, Horizon Kinetics Medical ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Horizon Kinetics Medical ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDXHorizon Kinetics Medical ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 14
Regencell Bioscience Holdings [RGC] is down 11.8% over the past day.
Buy
52
SLP alert for Apr 14
Simulations Plus [SLP] is up 4.69% over the past day.
Sell
38
ZLAB alert for Apr 14
Zai Lab [ZLAB] is up 6.77% over the past day.
